Rexulti, generically known as brexpiprazole, is an atypical antipsychotic medication primarily prescribed for the treatment of schizophrenia and as an adjunct therapy for major depressive disorder (MDD). Developed by Otsuka Pharmaceutical and Lundbeck, Rexulti has gained attention for its efficacy and tolerability. However, the cost of Rexulti can be a concern for many patients. This article delves into the cost, potential savings options, and essential usage information for Rexulti. Understanding the Cost of Rexulti The […]
